Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules Lavalaye

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 5, 2016
[Not Available]Jules Lavalaye, Marnix G E H Lam, J F Fred Verzijlbergen, et al.
Psychopharmacology|February 28, 2002
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary reportLiesbeth Reneman, Jan Booij, Jules Lavalaye, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 15, 2020
Is there any additional value to 68Ga-PSMA PET/CT in patients with suspicion of prostate cancer despite negative MRI and systematic biopsy?Joris G Heetman, Jules Lavalaye, Sandrine van Selm, et al.
The Journal of Urology|April 14, 2020
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer. ReplyLudwike van Kalmthout, Arthur Braat, Bart de Keizer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2022
Current research topics in FAPI theranostics: a bibliometric analysisAndor F van den Hoven, Ruth G M Keijsers, Marnix G E H Lam, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[PSMA PET, an important addition in prostate cancer diagnostics]Esmée C A van der Sar, Jules Lavalaye, Arthur J A T Braat, et al.
Molecular Imaging and Biology|July 31, 2008
Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PETJules Lavalaye, Jan C Grutters, Ewoudt M W van de Garde, et al.
Annals of Surgery|July 27, 2022
Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE TrialClaudia A Bargon, Anne Huibers, Danny A Young-Afat, et al.
European Urology Oncology|June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
Insights Into Imaging|August 13, 2022
Cost-effectiveness of the implementation of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT at initial prostate cancer stagingEsmée C A van der Sar, Willem R Keusters, Ludwike W M van Kalmthout, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|May 5, 2016
[Not Available]Jules Lavalaye, Marnix G E H Lam, J F Fred Verzijlbergen, et al.
Psychopharmacology|February 28, 2002
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary reportLiesbeth Reneman, Jan Booij, Jules Lavalaye, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 15, 2020
Is there any additional value to 68Ga-PSMA PET/CT in patients with suspicion of prostate cancer despite negative MRI and systematic biopsy?Joris G Heetman, Jules Lavalaye, Sandrine van Selm, et al.
The Journal of Urology|April 14, 2020
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer. ReplyLudwike van Kalmthout, Arthur Braat, Bart de Keizer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2022
Current research topics in FAPI theranostics: a bibliometric analysisAndor F van den Hoven, Ruth G M Keijsers, Marnix G E H Lam, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[PSMA PET, an important addition in prostate cancer diagnostics]Esmée C A van der Sar, Jules Lavalaye, Arthur J A T Braat, et al.
Molecular Imaging and Biology|July 31, 2008
Imaging of fibrogenesis in patients with idiopathic pulmonary fibrosis with cis-4-[(18)F]-Fluoro-L: -proline PETJules Lavalaye, Jan C Grutters, Ewoudt M W van de Garde, et al.
Annals of Surgery|July 27, 2022
Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE TrialClaudia A Bargon, Anne Huibers, Danny A Young-Afat, et al.
European Urology Oncology|June 9, 2023
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)Joris G Heetman, Jules Lavalaye, Pepijn D Polm, et al.
Insights Into Imaging|August 13, 2022
Cost-effectiveness of the implementation of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT at initial prostate cancer stagingEsmée C A van der Sar, Willem R Keusters, Ludwike W M van Kalmthout, et al.
Pageof 4